1. Leis, JF . Hematopoietic stem cell sources and donor selection. In: Maziarz, RT, Slater, SS (eds) Blood and marrow transplant handbook: comprehensive guide for patient care. 2nd ed. Portland, Oregon: Springer, 2015, pp. 29–41.
Google Scholar | Crossref2. Carreras, E, Dufour, C, Mohty, M, et al. The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies. 7th ed. Cham, Switzerland: Springer, 2019.
Google Scholar | Crossref3. Masszi, T, Mank, A. Supportive care. In: Apperley, J, Carreras, E, Gluckman, E, Masszi, T (eds) The EBMT handbook. 6th ed. Geneva, Switzerland: European Society for Blood and Marrow Transplantation, 2012, pp. 157–173.
Google Scholar4. Barboza-Zanetti, MO, Barboza-Zanetti, AC, Rodrigues-Abjaude, SA, et al. Clinical pharmacists’ contributions to hematopoietic stem cell transplantation: a systematic review. J Oncol Pharm Pract 2019; 25: 423–433.
Google Scholar | SAGE Journals | ISI5. Merten, JA, Shapiro, JF, Gulbis, AM, et al. Utilization of collaborative practice agreements between physicians and pharmacists as a mechanism to increase capacity to care for hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2013; 19: 509–518.
Google Scholar | Crossref | Medline | ISI6. Clemmons, AB, Alexander, M, DeGregory, K, et al. The hematopoietic cell transplant pharmacist: roles, responsibilities, and recommendations from the ASBMT pharmacy sig. Biol Blood Marrow Transplant 2018; 24: 914–922.
Google Scholar | Crossref | Medline7. Chan, A-W, Tetzlaff, JM, Altman, DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013; 158: 200–207.
Google Scholar | Crossref | Medline | ISI8. Rotta, I, Salgado, TM, Felix, DC, et al. Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT. J Eval Clin Pract 2015; 21: 584–590.
Google Scholar | Crossref | Medline9. Raehl, CL, Bond, CA, Woods, T, et al. Individualized drug use assessment in the elderly. Pharmacotherapy 2002; 22: 1239–1248.
Google Scholar | Crossref | Medline | ISI10. Svarstad, BL, Chewning, BA, Sleath, BL, et al. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 1999; 37: 113–124.
Google Scholar | Crossref | Medline | ISI11. Zierler-Brown, S, Brown, TR, Chen, D, et al. Clinical documentation for patient care: models, concepts, and liability considerations for pharmacists. Am J Health Syst Pharm 2007; 64: 1851–1858.
Google Scholar | Crossref | Medline | ISI12. Reis, WCT, Scopel, CT, Correr, CJ, et al. Analysis of clinical pharmacist interventions in a tertiary teaching hospital in Brazil. Einstein 2013; 11: 190–196.
Google Scholar | Crossref13. World Health Organization . ATC/DDD: international language for drug utilization research, http://www.whocc.no/ (2021, accessed 02 February 2021).
Google Scholar14. American College of Clinical Pharmacy . Standards of practice for clinical pharmacists. Pharmacother J Hum Pharmacol Drug Ther 2014; 34: 794–797.
Google Scholar | Crossref | Medline15. Cipolle, RJ, Strand, LM, Morley, PC. Pharmaceutical care practice: the clinician‘s guide. 2nd ed. New York, NY: McGraw-Hill, 2004.
Google Scholar16. Rodrigues, JPV, Marques, FA, Gonçalves, AMRF, et al. Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital. PLoS One 2019; 14: e0210779.
Google Scholar | Crossref | Medline17. Overhage, JM, Lukes, A. Practical, reliable, comprehensive method for characterizing pharmacists’ clinical activities. Am J Health Syst Pharm 1999; 56: 2444–2450.
Google Scholar | Crossref | Medline | ISI18. Fernandez-Llamazares, CM, Calleja-Hernández, M-Á, Manrique-Rodríguez, S, et al. Prescribing errors intercepted by clinical pharmacists in paediatrics and obstetrics in a tertiary hospital in Spain. Eur J Clin Pharmacol 2012; 68: 1339–1345.
Google Scholar | Crossref | Medline | ISI19. Glotzbecker, B, Duncan, C, Alyea, E, et al. Important drug interactions in hematopoietic stem cell transplantation: what every physician should know. Biol Blood Marrow Transplant 2012; 18: 989–1006.
Google Scholar | Crossref | Medline | ISI20. Valverde, IA, da Silva, MJ, Retto, MP. Association between potential drug interactions and clinical outcomes in hematopoietic stem cell transplantations. J Oncol Pharm Pract 2019; 25: 1105–1111.
Google Scholar | SAGE Journals | ISI21. Espinosa, MdP, Carrasco, MSD, Salinas, AS, et al. Potential drug-drug interactions in hospitalised haematological patients. J Oncol Pharm Pract 2017; 23: 443–453.
Google Scholar | SAGE Journals22. Maziarz, RT, Slater, SS. Blood and marrow transplant handbook: comprehensive guide for patient Care. 2nd ed. Portland, Oregon: Springer, 2015.
Google Scholar | Crossref23. Guignard, B, Bonnabry, P, Perrier, A, et al. Drug-related problems identification in general internal medicine: the impact and role of the clinical pharmacist and pharmacologist Eur J Intern Med 2015; 26: 399–406.
Google Scholar | Crossref | Medline24. Bauters, T, Bordon, V, Vandenbroucke, J, et al. Clinical pharmacy activities in a pediatric hematopoietic stem cell transplantation unit. J Oncol Pharm Pract 2014; 20: 15.
Google Scholar25. Bauters, T, Van Schandevyl, G, Laureys, G. Safety in the use of vaseline during oxygen therapy: the pharmacist’s perspective. Int J Clin Pharm 2016; 38: 1032–1034.
Google Scholar | Crossref | Medline26. World Health Organization . Medication safety in transitions of care, http://apps.who.int/bookorders (2019, accessed 02 June 2021).
Google Scholar27. Prot-Labarthe, S, Therrien, R, Demanche, C, et al. Pharmaceutical care in an inpatient pediatric hematopoietic stem cell transplant service. J Oncol Pharm Pract 2008; 14: 147–152.
Google Scholar | SAGE Journals28. Wu, HT, Graff, LR, Yuen, CW. Clinical pharmacy in an inpatient leukemia and bone marrow transplant service. Am J Heal Pharm 2005; 62: 744–747.
Google Scholar | Crossref | Medline29. Bubalo, J, Carpenter, PA, Majhail, N, et al. Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American society for blood and marrow transplantation practice guideline committee. Biol Blood Marrow Transplant 2014; 20: 600–616.
Google Scholar | Crossref | Medline | ISI30. Hanley, MJ, Abernethy, DR, Greenblatt, DJ. Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet 2010; 49: 71–87.
Google Scholar | Crossref | Medline | ISI31. Langebrake, C, Bernhardt, F, Baehr, M, et al. Drug dosing and monitoring in obese patients undergoing allogenic stem cell transplantation. Int J Clin Pharm 2011; 33: 918–924.
Google Scholar | Crossref | Medline32. Giguère, A, Zomahoun, HTV, Carmichael, PH, et al. Printed educational materials: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2012; 10: CD004398.
Google Scholar | Medline33. Chieng, R, Coutsouvelis, J, Poole, S, et al. Improving the transition of highly complex patients into the community: impact of a pharmacist in an allogeneic stem cell transplant (SCT) outpatient clinic. Support Care Cancer 2013; 21: 3491–3495.
Google Scholar | Crossref | Medline34. Corrêa, PM, Zuckermann, J, Fischer, GB, et al. Immunosuppressive serum levels in allogeneic hematopoietic stem cell transplantation: pharmaceutical care contribution. Pharm Pract (Granada) 2016; 14: 83.
Google Scholar | Crossref35. Ho, L, Akada, K, Messner, H, et al. Pharmacist’s role in improving medication safety for patients in an allogeneic hematopoietic cell transplant ambulatory clinic. Can J Hosp Pharm 2013; 66: 110–117.
Google Scholar | Medline36. Taylor, TL, Dupuis, LL, Nicksy, D, et al. Clinical pharmacy services in a pediatric hematology/oncology clinic: a description and assessment. Can J Hosp Pharm 1999; 52: 18–23.
Google Scholar37. Butow, P, Palmer, S, Pai, A, et al. Review of adherence-related issues in adolescents and young adults with cancer. J Clin Oncol 2010; 28: 4800–4809.
Google Scholar | Crossref | Medline | ISI38. Morrison, CF, Martsolf, DM, Wehrkamp, N, et al. Medication adherence in hematopoietic stem cell transplantation: a review of the literature. Biol Blood Marrow Transplant 2017; 23: 562–568.
Google Scholar | Crossref | Medline39. Zanetti, MOB, Pereira, LRL. Drugs use after hematopoietic stem cell transplantation: development of an educational material. J Appl Pharm Sci 2020; 7: 82–87.
Google Scholar40. Eckman, MH, Wise, R, Leonard, AC, et al. Impact of health literacy on outcomes and effectiveness of an educational intervention in patients with chronic diseases. Patient Educ Couns 2012; 87: 143–151.
Google Scholar | Crossref | Medline